Propanc Pancreatic Treatment Meets FDA Milestone
Cancer patients with pancreatic, ovarian, or colorectal tumors have reason for hope. A solid tumor treatment known as PRP, developed by Propanc Biopharma Inc. (PPCB),
April 27, 2025
Cancer patients with pancreatic, ovarian, or colorectal tumors have reason for hope. A solid tumor treatment known as PRP, developed by Propanc Biopharma Inc. (PPCB),